Literature DB >> 22488490

Chemical shift-induced phase errors in phase-contrast MRI.

Matthew J Middione1, Daniel B Ennis.   

Abstract

Phase-contrast magnetic resonance imaging is subject to numerous sources of error, which decrease clinical confidence in the reported measures. This work outlines how stationary perivascular fat can impart a significant chemical shift induced phase-contrast magnetic resonance imaging measurement error using computational simulations, in vitro, and in vivo experiments. This chemical shift error does not subtract in phase difference processing, but can be minimized with proper parameter selection. The chemical shift induced phase errors largely depend on both the receiver bandwidth and the TE. Both theory and an in vivo comparison of the maximum difference in net forward flow between vessels with and without perivascular fat indicated that the effects of chemically shifted perivascular fat are minimized by the use of high bandwidth (814 Hz/px) and an in-phase TE (high BW-TE(IN)). In healthy volunteers (N = 10) high BW-TE(IN) significantly improves intrapatient net forward flow agreement compared with low bandwidth (401 Hz/px) and a mid-phase TE as indicated by significantly decreased measurement biases and limits of agreement for the ascending aorta (1.8 ± 0.5 mL vs. 6.4 ± 2.8 mL, P = 0.01), main pulmonary artery (2.0 ± 0.9 mL vs. 11.9 ± 5.8 mL, P = 0.04), the left pulmonary artery (1.3 ± 0.9 mL vs. 5.4 ± 2.5 mL, P = 0.003), and all vessels (1.7 ± 0.8 mL vs. 7.2 ± 4.4 mL, P = 0.001).
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22488490      PMCID: PMC3396715          DOI: 10.1002/mrm.24262

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  38 in total

1.  Minimizing TE in moment-nulled or flow-encoded two- and three-dimensional gradient-echo imaging.

Authors:  M A Bernstein; A Shimakawa; N J Pelc
Journal:  J Magn Reson Imaging       Date:  1992 Sep-Oct       Impact factor: 4.813

2.  T1, T2 relaxation and magnetization transfer in tissue at 3T.

Authors:  Greg J Stanisz; Ewa E Odrobina; Joseph Pun; Michael Escaravage; Simon J Graham; Michael J Bronskill; R Mark Henkelman
Journal:  Magn Reson Med       Date:  2005-09       Impact factor: 4.668

3.  MR measurement of visceral fat: assessment of metabolic syndrome.

Authors:  Shigeko Tanaka; Minoru Yoshiyama; Yukihiro Imanishi; Koichi Nakahira; Takashi Hanaki; Yukari Naito; Mizue Imai; Masahiro Tanaka
Journal:  Magn Reson Med Sci       Date:  2006-12       Impact factor: 2.471

4.  Measuring visceral fat with water-selective suppression methods (SPIR, SPAIR) in patients with metabolic syndrome.

Authors:  Shigeko Tanaka; Minoru Yoshiyama; Yukihiro Imanishi; Masakazu Teragaki; Noriaki Kasayuki; Naruhito Shimizu; Koichi Nakahira; Takashi Hanaki; Yukari Naito; Masahiro Tanaka; Yuichi Inoue
Journal:  Magn Reson Med Sci       Date:  2007       Impact factor: 2.471

5.  Baseline correction of phase contrast images improves quantification of blood flow in the great vessels.

Authors:  Alexander Chernobelsky; Oleg Shubayev; Cindy R Comeau; Steven D Wolff
Journal:  J Cardiovasc Magn Reson       Date:  2007       Impact factor: 5.364

6.  Generalized k-space decomposition with chemical shift correction for non-Cartesian water-fat imaging.

Authors:  Ethan K Brodsky; James H Holmes; Huanzhou Yu; Scott B Reeder
Journal:  Magn Reson Med       Date:  2008-05       Impact factor: 4.668

7.  Analysis of noise in phase contrast MR imaging.

Authors:  A H Andersen; J E Kirsch
Journal:  Med Phys       Date:  1996-06       Impact factor: 4.071

8.  Concomitant gradient terms in phase contrast MR: analysis and correction.

Authors:  M A Bernstein; X J Zhou; J A Polzin; K F King; A Ganin; N J Pelc; G H Glover
Journal:  Magn Reson Med       Date:  1998-02       Impact factor: 4.668

Review 9.  Flow quantification and analysis methods.

Authors:  N J Pelc
Journal:  Magn Reson Imaging Clin N Am       Date:  1995-08       Impact factor: 2.266

10.  Quantitative magnetic resonance flow imaging.

Authors:  N J Pelc; F G Sommer; K C Li; T J Brosnan; R J Herfkens; D R Enzmann
Journal:  Magn Reson Q       Date:  1994-09
View more
  6 in total

1.  Noninvasive measurement of pressure gradient across a coronary stenosis using phase contrast (PC)-MRI: A feasibility study.

Authors:  Zixin Deng; Zhaoyang Fan; Sang-Eun Lee; Christopher Nguyen; Yibin Xie; Jianing Pang; Xiaoming Bi; Qi Yang; Byoung-Wook Choi; Jung-Sun Kim; Daniel Berman; Hyuk-Jae Chang; Debiao Li
Journal:  Magn Reson Med       Date:  2016-12-26       Impact factor: 4.668

2.  Off-resonance insensitive complementary SPAtial Modulation of Magnetization (ORI-CSPAMM) for quantification of left ventricular twist.

Authors:  Meral Reyhan; Yutaka Natsuaki; Daniel B Ennis
Journal:  J Magn Reson Imaging       Date:  2013-04-26       Impact factor: 4.813

3.  Flow-induced signal misallocation artifacts in two-point fat-water chemical shift MRI.

Authors:  Mahdi Salmani Rahimi; James H Holmes; Kang Wang; Scott B Reeder; Frank R Korosec
Journal:  Magn Reson Med       Date:  2014-06-09       Impact factor: 4.668

4.  Intra- and interscan reproducibility using Fourier Analysis of STimulated Echoes (FAST) for the rapid and robust quantification of left ventricular twist.

Authors:  Meral Reyhan; Hyun J Kim; Matthew S Brown; Daniel B Ennis
Journal:  J Magn Reson Imaging       Date:  2013-04-30       Impact factor: 4.813

5.  Phase Error Correction in Time-Averaged 3D Phase Contrast Magnetic Resonance Imaging of the Cerebral Vasculature.

Authors:  M Ethan MacDonald; Nils D Forkert; G Bruce Pike; Richard Frayne
Journal:  PLoS One       Date:  2016-02-24       Impact factor: 3.240

Review 6.  Cardiovascular magnetic resonance phase contrast imaging.

Authors:  Krishna S Nayak; Jon-Fredrik Nielsen; Matt A Bernstein; Michael Markl; Peter D Gatehouse; Rene M Botnar; David Saloner; Christine Lorenz; Han Wen; Bob S Hu; Frederick H Epstein; John N Oshinski; Subha V Raman
Journal:  J Cardiovasc Magn Reson       Date:  2015-08-09       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.